In the past one year, the Nifty Pharma Index has shed 12.4% as against the 1% gains in the benchmark Nifty 50. Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an average, according to Value Research.
Select SFBs and MFI players positioned for earnings upside: Rajiv Mehta
Non-banking financial companies are demonstrating early resilience, with collections holding firm across key segments like vehicle finance and microfinance. Despite lingering macroeconomic uncertainties and inflation,